The July 2012 issue of Health Affairs, published Monday, examines the impact of PEPFAR, focusing on “the origins of the program; the lessons learned from implementation; the successes achieved in terms of human health and well-being; and the opportunities that now exist to lay the groundwork for an ‘AIDS-free generation,'” the Health Affairs Blog reports, noting, “The new Health Affairs issue will be discussed [Tuesday] morning at a Washington, D.C., briefing” (Fleming, 7/10). U.S. Global AIDS Coordinator Ambassador Eric Goosby will deliver keynote remarks at the briefing, a U.S. Department of State press notice reports (7/9). In a paper to be discussed at the event, Kartik Venkatesh, an M.D./Ph.D. graduate student at Brown University, writes that PEPFAR’s adoption of generic drug usage made the program “a success,” a Brown University press release notes (7/9). In another study assessing the effects of PEPFAR-supported HIV programs, researchers at Columbia University’s Mailman School of Public Health found “PEPFAR-funded, HIV-related projects were linked to more deliveries in health facilities,” according to a Columbia University press release (7/9). 

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

Tags

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.